Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Watson Pharmaceutical (14 generic products)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Fourteen generic drug components. The fourteen products include five generic products marketed in the United States, eight abbreviated new drug applications and a generic product in late-stage development.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Clonshaugh Business and Technology Park
  • Coolock
  • Dublin E400
  • Ireland

Watson Pharmaceutical (14 generic products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Watson Pharmaceutical (14 generic products)‘s full profile, request access.

Request full access to PitchBook

Watson Pharmaceutical (14 generic products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Watson Pharmaceutical (14 generic products)‘s full profile, request access.

Request full access to PitchBook